Are you a new member? Sign up now
Login area
| Sign up
close
REMICADE - 100mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AB02 | BioTech | Infliximab - 100mg | 4028 | 23638/06 | REMICADE | 100mg | 1 | Injectable concentrated powder for solution | Infusion | Abela Frères S.A.L. | Cilag AG | Switzerland | 30,111,023 L.L | 19.35 | D | Janssen Biologics BV | The Netherlands | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AB02 | BioTech | Infliximab - 100mg | 10266 | 48720/1 | IXIFI | 100mg | 1 | Injectable powder for concentrate for solution | Infusion | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 23,911,751 L.L | 19.35 | D | Pfizer Japan Inc. | Japan | 2/5/2024 | 0 |
| L04AB02 | BioTech | Infliximab - 100mg | 9859 | 66716/1 | REMSIMA | 100mg | 1 | Injectable concentrated powder for solution | Infusion | Droguerie Mercury S.A.L. | Celltrion Inc., secondary packed by Hikma Pharmaceuticals, Jordan | Korea | 24,977,587 L.L | 19.35 | D | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| L04AB02 | BioTech | Infliximab - 100mg | 10266/388 | 48720/1 | IXIFI | 100mg | 1 | Injectable powder for concentrate for solution | Infusion | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | L.L | 19.35 | D | Pfizer Japan Inc. | Japan | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024